Simionescu L, Dumitriu L, Balmeş E, Aman E, Zamfir-Grigorescu D, Ursu H
Endocrinologie. 1986 Oct-Dec;24(4):257-70.
A simple, rapid haemagglutination laboratory kit was developed for the measurement of the thyroglobulin autoantibodies (Tgl-AAb). The Tgl-AAb kit was applied to the measurement of the AAbs titres in the sera collected from 2861 endocrine patients either hospitalized in the Institute of Endocrinology (about 75%) or endocrine outpatients--the great part of patients (over 90%) being however diagnosed as thyroid disorders. The sex classification showed the F/M ratio 6.61/1 for the whole group and 7.4/1 for the positive cases. The prevalence of the Tgl-AAbs positive sera at low titre (under 1:200) is 11.6% about twofold higher than in a population of 700 blood donors (6.4%), previously reported. Among the significant Tgl-AAbs titres, chosen more or less arbitrarily over 1:200, 30.47% of the patients have titres in the range 1:200-1:5000. The Tgl-AAbs positive and negative sera are classified and analysed according to the endocrine pathology but especially thyroid disorders and the positive thyroid disease are grouped by low, high and very high Tgl-AAbs titres and by Tgl-precipitin positive. Our results are rather similar to those reported for endocrine collectivities in other countries. The technical and methodological sources of some discrepancies between the laboratory Tgl-AAbs results and the clinical symptoms and/or anatomo-pathologic results are commented as well as some of the future perspectives of the laboratory investigation of the thyroid autoimmune diseases. Concluding, a strategy schema for a possible immunogram is presented.
开发了一种用于测量甲状腺球蛋白自身抗体(Tgl - AAb)的简单、快速血凝实验室试剂盒。将该Tgl - AAb试剂盒应用于测量从2861例内分泌患者血清中AAb的滴度,这些患者要么在内分泌研究所住院(约75%),要么是内分泌门诊患者——然而,大部分患者(超过90%)被诊断为甲状腺疾病。性别分类显示,整个组的女性/男性比例为6.61/1,阳性病例为7.4/1。低滴度(低于1:200)的Tgl - AAbs阳性血清患病率为11.6%,比先前报道的700名献血者群体中的患病率(6.4%)高出约两倍。在或多或少任意选择的高于1:200的显著Tgl - AAbs滴度中,30.47%的患者滴度在1:200 - 1:5000范围内。根据内分泌病理学,尤其是甲状腺疾病,对Tgl - AAbs阳性和阴性血清进行分类和分析,阳性甲状腺疾病按低、高和非常高的Tgl - AAbs滴度以及Tgl - 沉淀素阳性进行分组。我们的结果与其他国家报道的内分泌群体的结果相当相似。还对实验室Tgl - AAbs结果与临床症状和/或解剖病理结果之间一些差异的技术和方法学来源以及甲状腺自身免疫性疾病实验室研究的一些未来前景进行了评论。最后,提出了一种可能的免疫图谱策略方案。